Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency (Q89846): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Transtorno endócrino incomum e potencialmente letal de hiperplasia adrenal congênita (HAC). Esse diagnóstico é devido à deficiência de 3-beta-hidroxiesteroide desidrogenase. | |||
| description / en | description / en | ||
This is an endocrine disorder that is an uncommon and potentially lethal form of congenital adrenal hyperplasia (CAH). This diagnosis is due to 3-beta-hydroxysteroid dehydrogenase deficiency. | |||
Revision as of 16:42, 15 August 2026
This is an endocrine disorder that is an uncommon and potentially lethal form of congenital adrenal hyperplasia (CAH). This diagnosis is due to 3-beta-hydroxysteroid dehydrogenase deficiency.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_929626064 |
||
| English | Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency |
This is an endocrine disorder that is an uncommon and potentially lethal form of congenital adrenal hyperplasia (CAH). This diagnosis is due to 3-beta-hydroxysteroid dehydrogenase deficiency. |
